CMS Launches ACO LEAD: A Decade-long Commitment to Expanding Value-based care in Customary Medicare
The future of value-based care in traditional Medicare has taken shape with the launch of the Accountable Care Institution (ACO) LEAD model by the Centers for Medicare & Medicaid Services (CMS). This new initiative arrives as the ACO REACH program nears its expiration, offering a long-term pathway for the over 2.5 million Medicare beneficiaries and the 4,000+ healthcare providers currently participating in that model. ACO LEAD isn’t simply a continuation of its predecessor; it represents a notable evolution, designed to address past limitations and accelerate the adoption of value-based care, particularly for vulnerable populations and in underserved areas.
Addressing the Void Left by ACO REACH
The impending end of ACO REACH created uncertainty for providers deeply invested in the model. ACO LEAD directly addresses this concern,providing a stable,decade-long framework for continued participation and expansion of accountable care. This extended timeframe – the longest ever established by CMS for an ACO model – is a critical differentiator, offering a level of predictability previously unavailable. Instead of periodic benchmark resets, ACO LEAD will maintain initial benchmarks throughout the entire 10-year performance period, empowering physician groups to make long-term investments in infrastructure and care coordination with greater confidence.
Building on the Foundation of ACO REACH: Risk Sharing and Adaptability
ACO LEAD retains core elements of ACO REACH that have proven effective. Like its predecessor, the model offers two voluntary risk-sharing tracks:
* Global Risk Track: ACOs can earn up to 100% of savings generated through improved care coordination and efficiency, but also assume 100% of losses relative to established benchmarks.
* Professional Risk Track: A more moderate option, allowing ACOs to receive up to 50% of savings while assuming up to 50% of losses.
Furthermore, ACO LEAD preserves the flexible capitated payment structure, enabling providers to contract with other value-based care partners, fostering a collaborative ecosystem.
A new Focus: Reaching High-Needs Patients and Bridging the Medicare-Medicaid Divide
While building on existing strengths,ACO LEAD introduces key enhancements designed to broaden the reach of value-based care. A central focus is improving care for patients with complex health needs. CMS intends to incorporate more accurate risk adjustment methodologies (specific details are forthcoming) to better account for the unique challenges of caring for these individuals, incentivizing ACOs to integrate them into comprehensive care plans rather than managing them separately.
Recognizing the significant overlap between Medicare and Medicaid populations, ACO LEAD also prioritizes better coordination of care for dual-eligible beneficiaries. CMS plans a phased approach, beginning with identifying two states for a collaborative planning phase (March 2026 – December 2027) to develop frameworks for partnerships between Medicare ACOs and their Medicaid counterparts. This initiative has the potential to streamline care,reduce duplication,and improve outcomes for a particularly vulnerable segment of the population.
Expanding Access and Supporting Rural providers
ACO LEAD demonstrates a commitment to equitable access to value-based care. Several provisions specifically target barriers faced by smaller and rural provider groups:
* Episode-Based Risk Arrangements: Participating providers can establish episode-based risk arrangements with specialists, fostering collaboration and accountability across the care continuum.
* Rural Provider Investment: An add-on payment will be available to rural healthcare providers to support investments in the necessary infrastructure to participate as ACOs.
* Reduced Patient Thresholds: New ACOs,including those in rural areas,will be able to qualify with fewer patients than typically required,lowering the barrier to entry.
Engaging Beneficiaries and Driving Participation
ACO LEAD also incorporates incentives to encourage Medicare beneficiaries to actively participate in the model. These include potential cost-sharing reductions for outpatient services and, by 2029, the option to “buy down” their Medicare prescription drug premiums – a significant benefit for those on fixed incomes.
Industry Response: A Positive Step Forward
The launch of ACO LEAD has been met with widespread approval from industry stakeholders. Accountable for Health lauded the model’s 10-year timeframe, predictable benchmarks, and enhanced care coordination tools, stating it “reflects lessons learned from prior ACO models and responds directly to barriers that have limited participation.” America’s Physician Groups echoed this sentiment, highlighting the model’s appeal to providers seeking a stable, long-term path forward. Analysts at Jefferies predict a “clear positive” impact for value-based care companies like Astrana, Agilon, and Privia, noting that the model signals a commitment from regulators to expand market accessibility.
**The Path Forward: A More
Keep reading